PURMX THERAPEUTICS
Hiroshima, Japan · Founded 2021
About
PURMX Therapeutics is a biopharmaceutical startup spun out of Hiroshima University, pioneering the use of natural microRNAs as nucleic acid drugs to treat intractable diseases including cancer. The company's lead pipeline asset, MIRX002, targets the 'Aging switch' concept and is undergoing a first-in-human investigator-initiated clinical trial for malignant pleural mesothelioma. PURMX operates a proprietary functional RNA screening platform and aims to develop nucleic acid medicines that completely cure cancer rather than merely prolonging survival. Founded in 2021, it has attracted backing from investors including the University of Tokyo Edge Capital (UTEC) and Keio Innovation Initiative.
Summary
PURMX THERAPEUTICS is a Biotech company based in Hiroshima, Japan, founded in 2021.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/purmx-therapeutics"><img src="https://indexed.vc/api/badge/company/purmx-therapeutics" alt="PURMX THERAPEUTICS on Indexed.vc" width="260" height="76" /></a>